Stock Detail
COMBIMATRIX CORPORATION
CBMX @ Yahoo Finance | CBMX Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $2.05 | $2.25 | $-0.09 | -4.20% | 0.00 | $2.14 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $2.25 | $1.96 | 6,356 | 21.95M | 4,129 | -2.56 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 2.38 | 2.22 | 2.09 | 1.93 | 1.80 |
Stock Profile
Acacia Research Corporation - CombiMatrix engages in the development of technologies and products in the areas of drug development, genetic analysis, nanotechnology research, defense, and homeland security markets. Its platform technologies produce customizable arrays, which are semiconductor-based tools for use in identifying and determining the roles of genes, gene mutations, and proteins. The company's technology application areas include genomics, proteomics, biosensors, drug discovery, drug development, diagnostics, combinatorial chemistry, material sciences, and nanotechnology. Its other technologies include molecular synthesis and screening methods for the discovery of potential new drugs. The company's products are designed to aid in the discovery and development of new drugs and diagnostics for human healthcare. It has collaboration with Novavax, Inc. to develop a technique for in-process monitoring of vaccine production. The company is headquartered in Mukilteo, Washington. Acacia Research Corporation - CombiMatrix operates as a division of Acacia Research Corporation.